Safety and immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy Chinese adults: two single-center, randomized, double-blind Phase 1 and Phase 2 trials

Kangning Wang, Jialei Hu, Huagen Chen, Zhu Wang, Xianchao Zhu, Hongxing Pan

Open source

DOI
10.1080/14760584.2026.2746803
Published
2026-10-22
Container
Expert Review of Vaccines
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14760584.2026.2746803,
  title = {Safety and immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy Chinese adults: two single-center, randomized, double-blind Phase 1 and Phase 2 trials},
  author = {Kangning Wang and Jialei Hu and Huagen Chen and Zhu Wang and Xianchao Zhu and Hongxing Pan},
  year = {2026},
  journal = {Expert Review of Vaccines},
  doi = {10.1080/14760584.2026.2746803},
  url = {https://doi.org/10.1080/14760584.2026.2746803}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy Chinese adults: two single-center, randomized, double-blind Phase 1 and Phase 2 trials
AU  - Kangning Wang
AU  - Jialei Hu
AU  - Huagen Chen
AU  - Zhu Wang
AU  - Xianchao Zhu
AU  - Hongxing Pan
PY  - 2026
JO  - Expert Review of Vaccines
DO  - 10.1080/14760584.2026.2746803
UR  - https://doi.org/10.1080/14760584.2026.2746803
ER  - 

APA

Wang, K., Hu, J., Chen, H., Wang, Z., Zhu, X., & Pan, H. (2026). Safety and immunogenicity of the 24-valent pneumococcal conjugate vaccine in healthy Chinese adults: two single-center, randomized, double-blind Phase 1 and Phase 2 trials. Expert Review of Vaccines. https://doi.org/10.1080/14760584.2026.2746803

Source records